 |
Conference Summary
Launched in 2000, this FASEB Science Research Conference (SRC) is dedicated to exploring emergent knowledge on rapid and genomic actions of nuclear receptors in health and disease. This year, the conference is jointly organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), which held its first bi-annual meeting in 1998 and has convened in Europe, North America, and Asia. This is the first conference organized by FASEB and RRSH and will be held virtually.
The conference achieves significant cross-fertilization of ideas and in-depth discussions by gathering scientists and clinicians working in endocrinology, metabolism, cancer, reproduction, and development. This SRC, co-organized by two societies, is unique in this regard and offers exposure to scientific discoveries that often translate into more effective medical therapies.
Learn more
*Registration for this conference will open early 2021.
Organizers
Daniel E. Frigo, PhD
Associate Professor, Departments of Cancer Systems Imaging and Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
Eric Prossnitz, PhDDistinguished Professor and Chief, Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico, and Maralyn S. Budke Endowed Chair in Cancer Chemical Biology and Therapeutics, UNM Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, USA
Zeynep Madak Erdogan, PhD
Assistant Professor, Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, USA
Matthias Barton, MD
Professor, Cardiology, University of Zürich, Switzerland
Franck Mauvais-Jarvis, MD, PhDPrice Goldsmith Professor of Nutrition and Professor of Medicine, Tulane University School of Medicine, and Director, Diabetes Discovery Research and Gender Medicine Laboratory, Tulane University Health Sciences Center, and Staff Physician, Endocrine Service, Southeastern Louisiana Veterans Affairs Medical Center, New Orleans, USA
Keynote Lecture
Donald P. McDonnell, PhD
Glaxo-Wellcome Professor of Molecular Cancer Biology, Department of Pharmacology and Cancer Biology, Duke University, and Co-Director, Women's Cancer Program, Duke Cancer Institute
